Nautilus Biotechnology Inc (NAUT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $295.50M
Last updated: Nov 17, 2026 at 11:06 AM ET
Nautilus Biotechnology Inc (NAUT) Competitors
The companies most similar to Nautilus Biotechnology are Precision BioSciences (DTIL), Sana Biotechnology (SANA) and Palisade Bio (PALI). By market cap, Nautilus Biotechnology ranks 6th of the 13 companies on this page; Sana Biotechnology (SANA) is the largest at $605.26M.
Peer Comparison
NAUT's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology (NAUT) | $295.50M | N/A | 630.2x | 0.0% | N/A | 0.0% | 0.00% |
| Precision BioSciences Inc (DTIL) | $288.76M | N/A | 4.4x | -85.6% | -38.3% | 37272.0% | 0.00% |
| Sana Biotechnology Inc (SANA) | $605.26M | N/A | N/A | 0.0% | -46.8% | 0.0% | 0.00% |
| Palisade Bio Inc (PALI) | $201.01M | N/A | 436.8x | 0.0% | N/A | 0.0% | 0.00% |
| Q32 Bio Inc (QTTB) | $260.64M | 2.5x | 5.2x | 60.0% | N/A | 0.0% | 0.00% |
| Galectin Therapeutics Inc (GALT) | $307.59M | N/A | N/A | 0.0% | 671.1% | 0.0% | 0.00% |
| Greenwich Lifesciences Inc (GLSI) | $219.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neurogene Inc (NGNE) | $495.37M | N/A | N/A | 0.0% | -28.5% | 0.0% | 0.00% |
| Regenxbio Inc (RGNX) | $505.18M | N/A | 3.1x | -113.9% | N/A | -69.2% | 0.00% |
| ProQR Therapeutics BV (PRQR) | $199.28M | N/A | 6.1x | -228.2% | N/A | 120.4% | 0.00% |
| SAB Biotherapeutics Inc (SABS) | $266.66M | N/A | N/A | 0.0% | N/A | -62.4% | 0.00% |
| Tevogen Bio Holdings Inc. (TVGN) | $406.59M | N/A | N/A | 0.0% | 2022.8% | 0.0% | 0.00% |
| Vanda Pharmaceuticals Inc (VNDA) | $241.27M | N/A | 1.0x | -119.9% | -84.7% | 24.1% | 0.00% |
| Peer median | $277.71M | 2.5x | 4.8x | 0.0% | -33.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Nautilus Biotechnology, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Precision BioSciences Inc (DTIL) | Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. | DTIL competitors |
| Sana Biotechnology Inc (SANA) | Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington. | SANA competitors |
| Palisade Bio Inc (PALI) | Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. | PALI competitors |
| Q32 Bio Inc (QTTB) | Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune... | QTTB competitors |
| Galectin Therapeutics Inc (GALT) | Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic... | GALT competitors |
| Greenwich Lifesciences Inc (GLSI) | Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /... | GLSI competitors |
| Neurogene Inc (NGNE) | Neurogene Inc. is an innovative biotechnology company at the forefront of developing advanced gene therapies for rare neurological disorders... | NGNE competitors |
| Regenxbio Inc (RGNX) | REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable... | RGNX competitors |
| ProQR Therapeutics BV (PRQR) | ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. | PRQR competitors |
| SAB Biotherapeutics Inc (SABS) | SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. | SABS competitors |
| Tevogen Bio Holdings Inc. (TVGN) | Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology... | TVGN competitors |
| Vanda Pharmaceuticals Inc (VNDA) | Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. | VNDA competitors |
Frequently Asked Questions About NAUT
Who are Nautilus Biotechnology's main competitors?
The companies most similar to Nautilus Biotechnology include Precision BioSciences (DTIL), Sana Biotechnology (SANA), Palisade Bio (PALI), Q32 Bio (QTTB) and Galectin Therapeutics (GALT), listed from the closest match.
Who is Nautilus Biotechnology's biggest competitor?
Sana Biotechnology (SANA) is the largest of the similar companies at $605.26M; Precision BioSciences (DTIL) is the closest match by business profile, size, sector and industry.
How does NAUT stock compare with its competitors?
NAUT's P/S is 630.2x against a peer median of 4.8x; its net margin is 0.0% against a peer median of 0.0%.
Which of Nautilus Biotechnology's competitors pays a higher dividend?
Nautilus Biotechnology pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Nautilus Biotechnology bigger than its competitors?
No. Nautilus Biotechnology is 6th by market cap among the 13 companies on this page; the largest is Sana Biotechnology (SANA) at $605.26M.
NAUT pages: Overview, Earnings, Forecast, Financials, Competitors